References
-
1.
Pourkarim MR, Razavi H, Lemey P, Van Ranst M. Iran's hepatitis elimination programme is under threat. Lancet. 2018;392(10152):1009. [PubMed ID: 30264697]. https://doi.org/10.1016/S0140-6736(18)31810-5.
-
2.
Thijssen M, Lemey P, Amini-Bavil-Olyaee S, Dellicour S, Alavian SM, Tacke F, et al. Mass migration to Europe: an opportunity for elimination of hepatitis B virus? Lancet Gastroenterol Hepatol. 2019;4(4):315-23. [PubMed ID: 30860067]. https://doi.org/10.1016/S2468-1253(19)30014-7.
-
3.
World Health Organizaiton. Acute hepatitis of unknown aetiology in children - Multi-country. Geneva, Switzerland: World Health Organizaiton; 2022. Available from: https://www.who.int/emergencies/disease-outbreak-news/item/DON-389.
-
4.
Murphy N. Scientist offers clues in mystery hepatitis outbreak in children. Abu Dhabi, UAE: The National; 2022, [updated May 17, 2022]. Available from: https://www.thenationalnews.com/health/2022/05/17/scientist-offers-clues-in-mystery-hepatitis-outbreak-in-children/.
-
5.
The Lancet Infectious Diseases. Explaining the unexplained hepatitis in children. Lancet Infect Dis. 2022;22(6):743. [PubMed ID: 35569492]. https://doi.org/10.1016/S1473-3099(22)00296-1.
-
6.
Lee B, Damon CF, Platts-Mills JA. Pediatric acute gastroenteritis associated with adenovirus 40/41 in low-income and middle-income countries. Curr Opin Infect Dis. 2020;33(5):398-403. [PubMed ID: 32773498]. [PubMed Central ID: PMC8286627]. https://doi.org/10.1097/QCO.0000000000000663.
-
7.
Porritt RA, Paschold L, Rivas MN, Cheng MH, Yonker LM, Chandnani H, et al. HLA class I-associated expansion of TRBV11-2 T cells in multisystem inflammatory syndrome in children. J Clin Invest. 2021;131(10). [PubMed ID: 33705359]. [PubMed Central ID: PMC8121516]. https://doi.org/10.1172/JCI146614.
-
8.
Brodin P, Arditi M. Severe acute hepatitis in children: investigate SARS-CoV-2 superantigens. Lancet Gastroenterol Hepatol. 2022. [PubMed ID: 35576952]. [PubMed Central ID: PMC9106421]. https://doi.org/10.1016/S2468-1253(22)00166-2.
-
9.
Espinosa L, Wijermans A, Orchard F, Czernichow T, Coletti P, Hermans L, et al. Early warning of public health threats using Twitter data. medRxiv. 2021. https://doi.org/10.1101/2021.03.25.21254342.
-
10.
Pourkarim MR, Van Espen L, Thijssen M, Van Ranst M, Pourkarim MR. How Adequate Social Media Management Supports the Viral Hepatitis Elimination Program. Hepat Mon. 2018;In Press(In Press). https://doi.org/10.5812/hepatmon.69791.
-
11.
Pourkarim MR, Nayebzadeh S, Alavian SM, Hataminasab SH. Digital Marketing: A Unique Multidisciplinary Approach towards the Elimination of Viral Hepatitis. Pathogens. 2022;11(6). https://doi.org/10.3390/pathogens11060626.
-
12.
Espinosa MF, Verbyla ME, Vassalle L, Leal C, Leroy-Freitas D, Machado E, et al. Reduction and liquid-solid partitioning of SARS-CoV-2 and adenovirus throughout the different stages of a pilot-scale wastewater treatment plant. Water Res. 2022;212:118069. [PubMed ID: 35077942]. [PubMed Central ID: PMC8759026]. https://doi.org/10.1016/j.watres.2022.118069.
-
13.
Hashemi SMA, Thijssen M, Hosseini SY, Tabarraei A, Pourkarim MR, Sarvari J. Human gene polymorphisms and their possible impact on the clinical outcome of SARS-CoV-2 infection. Arch Virol. 2021;166(8):2089-108. [PubMed ID: 33934196]. [PubMed Central ID: PMC8088757]. https://doi.org/10.1007/s00705-021-05070-6.
-
14.
Suk JE, Pharris A, Beaute J, Colzani E, Needham H, Kinsman J, et al. Public health considerations for transitioning beyond the acute phase of the COVID-19 pandemic in the EU/EEA. Euro Surveill. 2022;27(17). [PubMed ID: 35485272]. [PubMed Central ID: PMC9052765]. https://doi.org/10.2807/1560-7917.ES.2022.27.17.2200155.